Patents by Inventor Kimberly O. Cameron

Kimberly O. Cameron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EP4 receptor selective agonists in the treatment of osteoporosis
    Patent number: 6747054
    Abstract: This invention is directed to EP4 receptor selective prostaglandin agonists of the Formula I, wherein R2, X, Z and Q are as defined in the specification. This invention is also directed to pharmaceutical compositions containing those compounds. This invention is also directed to methods of treating conditions which present with low bone mass, particularly osteoporosis, frailty, an osteoporotic fracture, a bone defect, childhood idiopathic bone loss, alveolar bone loss, mandibular bone loss, bone fracture, osteotomy, bone loss associated with periodontitis, or prosthetic ingrowth in a mammal comprising administering those compounds.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: June 8, 2004
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, Bruce A. Lefker
  • EP4 receptor selective agonists in the treatment of osteoporosis
    Patent number: 6737437
    Abstract: This invention is directed to methods of treating conditions which present with low bone mass, particularly osteoporosis, frailty, an osteoporotic fracture, a bone defect, childhood idiopathic bone loss, alveolar bone loss, mandibular bone loss, bone fracture, osteotomy, bone loss associated with periodontitis, or prosthetic ingrowth comprising administering prostaglandin agonists which are EP4 receptor selective prostaglandin agonists. This invention is especially directed to those methods wherein the EP4 receptor selective agonist is a compound of Formula I: wherein the variables are as defined in the specification.
    Type: Grant
    Filed: December 15, 2000
    Date of Patent: May 18, 2004
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, HuaZhu Ke, Bruce A. Lefker, David D. Thompson
  • Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
    Publication number: 20030220494
    Abstract: This invention relates to compounds useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, prostatic disease, and the like, and to pharmaceutical composition, methods, and kits comprising such compounds.
    Type: Application
    Filed: April 2, 2003
    Publication date: November 27, 2003
    Inventors: Kimberly O. Cameron, Richard Chesworth, Paul A. DaSilva-Jardine, Robert F. Day, Bruce A. Lefker, Michael P. Zawistoski
  • Metabolites of (3-[[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid
    Publication number: 20030216445
    Abstract: The present invention relates to metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid.
    Type: Application
    Filed: January 29, 2003
    Publication date: November 20, 2003
    Inventors: Kimberly O. Cameron, Kim A. Johnson, Bruce A. Lefker, Chandra A. Prakash
  • Prevention of loss and restoration of bone mass by certain prostaglandin agonists
    Patent number: 6649657
    Abstract: Prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.
    Type: Grant
    Filed: September 26, 2002
    Date of Patent: November 18, 2003
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, Hua Z. Ke, Bruce A. Lefker, Robert L. Rosati, David D. Thompson
  • Methods of treatment with selective EP4 receptor agonists
    Publication number: 20030207925
    Abstract: The present invention provides a method of treating hypertension, liver failure, loss of patency of ductus arteriosus, glaucoma or ocular hypertension in a patient, comprising administering to the patient a therapeutically effective amount of a selective EP4 receptor agonist of Formula I 1
    Type: Application
    Filed: March 11, 2003
    Publication date: November 6, 2003
    Inventors: Kimberly O. Cameron, Bruce A. Lefker, Delvin R. Knight
  • EP4 receptor selective agonists in the treatment of osteoporosis
    Patent number: 6642266
    Abstract: This invention is directed to methods of treating conditions which present with low bone mass, particularly osteoporosis, frailty, an osteoporotic fracture, a bone defect, childhood idiopathic bone loss, alveolar bone loss, mandibular bone loss, bone fracture, osteotomy, bone loss associated with periodontitis, or prosthetic ingrowth comprising administering prostaglandin agonists which are EP4 receptor selective prostaglandin agonists. This invention is especially directed to those methods wherein the EP4 receptor selective agonist is a compound of Formula I: wherein the variables are as defined in the specification.
    Type: Grant
    Filed: November 16, 2001
    Date of Patent: November 4, 2003
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, HuaZhu Ke, Bruce A. Lefker, David D. Thompson
  • Use of selective EP4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
    Publication number: 20030176479
    Abstract: The present invention is directed to methods for treating liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension, comprising administering to the patient in need thereof a therapeutically effective amount of a selective EP4 receptor agonist of the Formulae 1
    Type: Application
    Filed: March 11, 2003
    Publication date: September 18, 2003
    Inventors: Kimberly O. Cameron, Bruce A. Lefker
  • Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
    Patent number: 6608203
    Abstract: This invention relates to compounds useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, prostatic disease, and the like, and to pharmaceutical composition, methods, and kits comprising such compounds.
    Type: Grant
    Filed: December 21, 2000
    Date of Patent: August 19, 2003
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, Richard Chesworth, Paul A. DaSilva-Jardine, Robert F. Day, Bruce A. Lefker, Michael P. Zawistoski
  • EP4 receptor selective agonists in the treatment of osteoporosis
    Publication number: 20030149086
    Abstract: This invention is directed to EP4 receptor selective prostaglandin agonists of the Formula I, 1
    Type: Application
    Filed: December 20, 2002
    Publication date: August 7, 2003
    Inventors: Kimberly O. Cameron, Bruce A. Lefker
  • Prostaglandin agonists
    Publication number: 20030078261
    Abstract: This invention relates to prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.
    Type: Application
    Filed: September 25, 2002
    Publication date: April 24, 2003
    Inventors: Kimberly O. Cameron, Bruce A. Lefker, Robert L. Rosati
  • EP4 receptor selective agonists in the treatment of osteoporosis
    Patent number: 6552067
    Abstract: This invention is directed to EP4 receptor selective prostaglandin agonists of the Formula I, wherein R2, X, Z and Q are as defined in the specification. This invention is also directed to pharmaceutical compositions containing those compounds. This invention is also directed to methods of treating conditions which present with low bone mass, particularly osteoporosis, frailty, an osteoporotic fracture, a bone defect, childhood idiopathic bone loss, alveolar bone loss, mandibular bone loss, bone fracture, osteotomy, bone loss associated with periodontitis, or prosthetic ingrowth in a mammal comprising administering those compounds.
    Type: Grant
    Filed: November 21, 2001
    Date of Patent: April 22, 2003
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, Bruce A. Lefker
  • Prostaglandin agonists
    Patent number: 6531485
    Abstract: This invention relates to prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.
    Type: Grant
    Filed: December 16, 1999
    Date of Patent: March 11, 2003
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, Paul A. DaSilva-Jardine
  • PROSTAGLANDIN AGONISTS
    Publication number: 20030008895
    Abstract: This invention relates to prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.
    Type: Application
    Filed: December 16, 1999
    Publication date: January 9, 2003
    Inventors: KIMBERLY O CAMERON, PAUL A. DASILVA-JARDINE
  • Prostaglandin agonists and their use to treat bone disorders
    Patent number: 6498172
    Abstract: This invention relates to prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.
    Type: Grant
    Filed: August 20, 1999
    Date of Patent: December 24, 2002
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, Bruce A. Lefker, Robert L. Rosati
  • Prevention of loss and restoration of bone mass by certain prostaglandin agonists
    Patent number: 6492412
    Abstract: Prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.
    Type: Grant
    Filed: June 29, 2001
    Date of Patent: December 10, 2002
    Assignee: Pfizer, Inc.
    Inventors: Kimberly O. Cameron, Hua Z. Ke, Bruce A. Lefker, Robert L. Rosati, David D. Thompson
  • Osteoporosis compounds
    Publication number: 20020165255
    Abstract: This invention relates to prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.
    Type: Application
    Filed: October 19, 2001
    Publication date: November 7, 2002
    Inventors: Kimberly O. Cameron, Bruce A. Lefker, Robert L. Rosati
  • Estrogen agonists/antagonists for preventing breast cancer
    Publication number: 20020132816
    Abstract: Compounds of this formula 1
    Type: Application
    Filed: May 16, 2002
    Publication date: September 19, 2002
    Inventors: Kimberly O. Cameron, Paul A. Dasilva-Jardine, Hua Zhu Ke, Robert L. Rosati
  • Estrogen agonists/antagonists
    Patent number: 6441193
    Abstract: Compounds of this formula are useful for treating or preventing, obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: August 27, 2002
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, Paul A. Dasilva-Jardine, Hua Zhu Ke, Robert L. Rosati
  • Prevention and treatment of skeletal disorder with EP2 receptor subtype selective prostaglandin E2 agonists
    Patent number: 6426359
    Abstract: This invention relates to the use of EP2 receptor subtype selective prostaglandin E2 agonists to augment bone mass including the prevention and treatment of skeletal disorders in mammals, including humans.
    Type: Grant
    Filed: June 11, 1999
    Date of Patent: July 30, 2002
    Assignee: Pfizer Inc.
    Inventors: Kimberly O. Cameron, Hua Z. Ke, Bruce A. Lefker, Robert L Rosati, David D. Thompson